不分离氨酸剂量对补充激活和在体外膜氧化过程中选择的细胞外囊泡群体的影响
Johannes Zipperle1, Laurenz Vock1, Gerhard Fritsch1,2
1Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA, 1200 Vienna, Austria.
International journal of molecular sciences
|October 26, 2024
概括
在体外膜氧化 (ECMO) 过程中较低的未分离氨酸 (UFH) 剂量会增加补体激活和内皮细胞外囊 (EVs). 较高的UFH剂量与红细胞衍生的EV相关,这表明EV可以监测ECMO抗凝.
科学领域:
- 心血管科学 心血管科学
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 体外膜氧化 (ECMO) 对于严重的心肺衰竭至关重要.
- 不分离的肝素 (UFH) 是标准的抗凝药,但可能导致出血.
- 细胞外囊泡 (EVs) 参与ECMO期间的凝血和炎症.
研究的目的:
- 调查UFH剂量在ECMO期间对凝血和炎症的影响.
- 分析循环的大型EV (lEV) 子集和补充激活的变化.
- 探索EVs在ECMO抗凝管理中的治疗潜力.
主要方法:
- 一个多中心随机对照试验的后期分析.
- 根据UFH剂量 (<15 IU/kg/h或更高) 分层23名静脉ECMO患者.
- 在ECMO启动,中期和后期阶段通过免疫测试和流细胞计评估补充激活 (C5a,sC5b-9) 和lEV群体 (内皮细胞,红细胞衍生,线粒体阳性).
主要成果:
- 低UFH剂量 (<15IU/kg/h) 的患者表现出更高的C5a和sC5b-9水平.
- 较低的UFH剂量与内皮衍生的LEVs的增加相关.
- 较高的UFH剂量与红细胞衍生和线粒体阳性LEVs的升高有关.
结论:
- 在ECMO期间的UFH剂量会影响凝血-炎症平衡.
- EV子集 (内皮细胞,红细胞衍生,线粒体阳性) 可能作为抗凝状态的生物标志物.
- 检测EV显示了监测ECMO患者的可视化潜力,为标准化和验证提供了进一步的研究.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
625
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
625
01:20Extrinsic and Intrinsic Pathways of Hemostasis
5.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
5.9K
01:29Venous Thrombosis III: Interprofessional Care
2
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
2